Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes

W Lee Hand1, Debra L Hand, Yvonne Vasquez

  • 1Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA. lee.hand@ttuhsc.edu

Insights

Type 2 diabetes patients exhibit heightened superoxide production in polymorphonuclear leukocytes (PMN), potentially increasing infection risk. Protein kinase C inhibitors and azithromycin reduced this oxidative burst activity in diabetic and control subjects.

Area of Science:

  • Immunology
  • Metabolic Disorders

Background:

  • Diabetes mellitus is associated with increased susceptibility to infections and chronic inflammation.
  • Hyperglycemia and metabolic abnormalities in diabetes may impact immune cell function, specifically polymorphonuclear leukocytes (PMN).

Purpose of the Study:

  • To evaluate oxidative respiratory burst activity (superoxide production) in PMN from type 2 diabetic patients compared to healthy controls.
  • To examine the effects of protein kinase C (PKC) inhibitors and azithromycin on PMN superoxide production.

Main Methods:

  • Assessed superoxide production in non-stimulated and stimulated (PMA, zymosan) PMN from 70 type 2 Hispanic diabetic patients and 70 healthy Hispanic controls.
  • Investigated the impact of PKC inhibitors and azithromycin on superoxide generation.

Main Results:

  • PMN from diabetic individuals showed significantly higher superoxide production at rest and upon stimulation compared to controls.
  • PKC inhibitors reduced superoxide production in PMN from both diabetic and control groups.
  • Azithromycin markedly inhibited superoxide generation in all tested PMN.

Conclusions:

  • Increased oxidative respiratory burst activity in PMN may contribute to infection and inflammation in type 2 diabetes.
  • PKC and azithromycin demonstrate potential as modulators of this heightened PMN response, warranting further investigation for therapeutic applications.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...